HomeNews & MediaPress ReleasesNidlegy™ Phase III PIVOTAL trial meets the study’s primary objective in patients with locally advanced fully resectable melanoma (Price Sensitive)Press ReleasePublishedOctober 16, 2023Also available inItalianoNidlegy™ Phase III PIVOTAL trial meets the study’s primary objective in patients with locally advanced fully resectable melanoma (Price Sensitive)See more details
